Page 38 - Read Online

14. Brown AS, Susser ES. Homocysteine and schizophrenia: from Nawroth PP. Hyperhomocyst (e) inemia and endothelial dysfunction
prenatal to adult life. Prog Neuropsychopharmacol Biol Psychiatry in IDDM. Diabetes Care 1998;21:841‑8.
2005;29:1175‑80. 30. Kulkarni K, Richard BC. Lifestyle, homocysteine, and the metabolic
15. Ansari R, Mahta A, Mallack E, Luo JJ. Hyperhomocysteinemia and syndrome. Metab Syndr Relat Disord 2003;1:141‑7.
neurologic disorders: a review. J Clin Neurol 2014;10:281‑8. 31. Giltay EJ, Hoogeveen EK, Elbers JM, Gooren LJ, Asscheman H,
16. Luo JJ, Sivaraaman K, Nouh A, Dun NJ. Elevated plasma level Stehouwer CD. Insulin resistance is associated with elevated
of homocysteine is an independent risk factor for peripheral plasma total homocysteine levels in healthy, non‑obese subjects.
neuropathy. Br J Med Med Res 2014;4:161‑9. Atherosclerosis 1998;139:197‑8.
17. Aminoff MJ. Aminoff’s Electrodiagnosis in Clinical Neurology. 32. Munshi MN, Stone A, Fink L, Fonseca V. Hyperhomocysteinemia
6th ed. Philadelphia: Saunders; 2012. following a methionine load in patients with non‑insulin‑dependent
18. Luo JJ, Bumanlag F, Dun NJ. Electrophysiologic features of diabetes mellitus and macrovascular disease. Metabolism
peripheral neuropathy in adults with an isolated elevated plasma 1996;45:133‑5.
level of homocysteine. J Neurol Transl Neurosci 2013;2:1027‑31. 33. Kawasaki A, Purvin VA, Burgett RA. Hyperhomocysteinaemia
19. Kruman II, Culmsee C, Chan SL, Kruman Y, Guo Z, Penix L, in young patients with non‑arteritic anterior ischaemic optic
Mattson MP. Homocysteine elicits a DNA damage response neuropathy. Br J Ophthalmol 1999;83:1287‑90.
in neurons that promotes apoptosis and hypersensitivity to 34. Kim WK, Pae YS. Involvement of N‑methyl‑d‑aspartate receptor
excitotoxicity. J Neurosci 2000;20:6920‑6. and free radical in homocysteine‑mediated toxicity on rat cerebellar
20. Lipton SA, Kim WK, Choi YB, Kumar S, D’Emilia DM, Rayudu PV, granule cells in culture. Neurosci Lett 1996;216:117‑20.
Arnelle DR, Stamler JS. Neurotoxicity associated with dual actions 35. Outinen PA, Sood SK, Liaw PC, Sarge KD, Maeda N, Hirsh J, Ribau J,
of homocysteine at the N‑methyl‑D‑aspartate receptor. Proc Natl Podor TJ, Weitz JI, Austin RC. Characterization of the stress‑inducing
Acad Sci U S A 1997;94:5923‑8. effects of homocysteine. Biochem J 1998;332:213‑21.
21. Tsivgoulis G, Spengos K, Karandreas N, Panas M, Kladi A, Manta P. 36. Huang RF, Huang SM, Lin BS, Wei JS, Liu TZ. Homocysteine
Presymptomatic neuromuscular disorders disclosed following statin thiolactone induces apoptotic DNA damage mediated by increased
treatment. Arch Intern Med 2006;166:1519‑24. intracellular hydrogen peroxide and caspase 3 activation in
22. Ammendola A, Gemini D, Iannaccone S, Argenzio F, Ciccone G, HL‑60 cells. Life Sci 2001;68:2799‑811.
Ammendola E, Serio L, Ugolini G, Bravaccio F. Gender and peripheral 37. Maler JM, Seifert W, Hüther G, Wiltfang J, Rüther E, Kornhuber J,
neuropathy in chronic alcoholism: a clinical‑electroneurographic Bleich S. Homocysteine induces cell death of rat astrocytes in vitro.
study. Alcohol Alcohol 2000;35:368‑71. Neurosci Lett 2003;347:85‑8.
23. Aaberg ML, Burch DM, Hud ZR, Zacharias MP. Gender differences 38. Mattson MP, Shea TB. Folate and homocysteine metabolism in
in the onset of diabetic neuropathy. J Diabetes Complications neural plasticity and neurodegenerative disorders. Trends Neurosci
2008;22:83‑7. 2003;26:137‑46.
24. Mathew PG, Dun EC, Luo JJ. A cyclic pain: the pathophysiology 39. Smith AD. The worldwide challenge of the dementias: a role for B
and treatment of menstrual migraine. Obstet Gynecol Surv vitamins and homocysteine? Food Nutr Bull 2008;29:S143‑72.
2013;68:130‑40. 40. Savage DG, Lindenbaum J. Neurological complications of acquired
25. Pirart J, Lauvaux JP, Rey W. Blood sugar and diabetic complications. cobalamin deficiency: clinical aspects. Baillieres Clin Haematol
N Engl J Med 1978;298:1149. 1995;8:657‑78.
26. Factors in development of diabetic neuropathy. Baseline analysis 41. Yi Y, Kang HJ, Shin HY, Kim K. Progressive myelopathy mimicking
of neuropathy in feasibility phase of Diabetes Control and subacute combined degeneration after intrathecal chemotherapy.
Complications Trial (DCCT). The DCCT Research Group. Diabetes J Child Neurol 2014;Epub ahead of print.
1988;37:476‑81. 42. Luo JJ, Dun NJ. Should homocysteine be a therapeutic target for
27. The effect of intensive diabetes therapy on the development and neurological disorders? Brain Disord Ther 2013;2:e107.
progression of neuropathy. The Diabetes Control and Complications
Trial Research Group. Ann Intern Med 1995;122:561‑8.
28. Liu XX, Wilson K, Charlton CG. Effects of L‑dopa treatment on Cite this article as: Luo JJ, Bumanlag F, Ansari R, Tang YM, Dun NJ. Central
methylation in mouse brain: implications for the side effects of somatosensory conduction slowing in adults with isolated elevated plasma
L‑dopa. Life Sci 2000;66:2277‑88. level of homocysteine. Neuroimmunol Neuroinflammation 2015;2(1):26-30.
29. Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Source of Support: Nil. Conflict of Interest: No.
Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Received: 18-08-2014; Accepted: 10-11-2014

30 Neuroimmunol Neuroinflammation | Volume 2 | Issue 1 | January 15, 2015